Laurel Wealth Advisors (California)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $434K | Sell |
|
|||||
|
2022
Q3 | $573K | Sell |
|
|||||
|
2022
Q2 | $541K | Sell |
|
|||||
|
2022
Q1 | $808K | Sell |
|
|||||
|
2021
Q4 | $1.71M | Sell |
|
|||||
|
2021
Q3 | $1.94M | Sell |
|
|||||
|
2021
Q2 | $2.24M | Sell |
|
|||||
|
2021
Q1 | $2.34M | Sell |
|
|||||
|
2020
Q4 | $2.63M | Buy |
|
|||||
|
2020
Q3 | $2.04M | Buy |
|
|||||
|
2020
Q2 | $1.93M | Buy |
|
|||||
|
2020
Q1 | $1.33M | Buy |
|
|||||
|
2019
Q4 | $1.27M | Sell |
|
|||||
|
2019
Q3 | $1.1M | Hold |
|
|||||
|
2019
Q2 | $1.26M | Sell |
|
|||||
|
2019
Q1 | $1.35M | Sell |
|
|||||
|
2018
Q4 | $1.19M | Sell |
|
|||||
|
2018
Q3 | $1.6M | Sell |
|
|||||
|
2018
Q2 | $1.72M | Sell |
|
|||||
|
2018
Q1 | $1.61M | Hold |
|
|||||
|
2017
Q4 | $1.56M | Sell |
|
|||||
|
2017
Q3 | $1.95M | Buy |
|
|||||
|
2017
Q2 | $1.2M | Buy |
|